Totals
- Total revenue
- $479,515
- Total expenses
- $413,797
- Contributions and grants received
- $783,546
- Grants paid
- $103,420
- Program service revenue
- $0
- Investment income
- $277,127
- Other revenue
- -$581,158
- Total assets, end of year
- $13,915,513
- Total liabilities, end of year
- $0
- Net assets or fund balances, end of year
- $13,915,513
- Program services expenses (Part IX)
- $118,653
- Management and general expenses
- $295,144
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $118,653
Program services were 28.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$783,546
-
1g · Noncash contributions included above
$100,007
-
3 · Investment income
total $277,127 · excluded $277,127
-
11a · Other revenue: K-1 CAPITAL LOSS
total -$581,158 · excluded -$581,158
-
11e · Other revenue, total
-$581,158
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $103,420 · program services $103,420
-
11a · Fees: management
total $20,000 · program services $10,000 · management and general $10,000
-
11g · Fees: other
total $4,800 · program services $4,800
-
24a · Other expenses: K-1 EXPENSES
total $285,144 · management and general $285,144
-
24b · Other expenses: PROGRAM EXPENSES
total $433 · program services $433
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $5,396,255 · end of year $2,952,947
-
2 · Savings and temporary cash investments
beginning of year $587,888 · end of year $2,325,777
-
11 · Investments: publicly traded securities
beginning of year $112,472 · end of year $213,337
-
12 · Investments: other securities
beginning of year $7,753,180 · end of year $8,423,452
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $13,849,795 · end of year $13,915,513
Mission and programs · 2024
Mission
TO SUPPORT ONGOING RESEARCH AND EDUCATION ON EPILEPSY AND ADVANCE NEW TREATMENTS AND CARE FOR PEOPLE LIVING WITH EPILEPSY.
-
PROVIDE FUNDING AND CONSULTING TO SUPPORT ONGOING RESEARCH AND EDUCATION ON EPILEPSY AND ADVANCE NEW TREATMENT AND CARE FOR PEOPLE LIVING WITH EPILEPSY.
Expenses $118,653 · Grants $103,420
As filed on the 2024 return.
Listed in Part VII
-
James LintottJAMES LINTOTT
PRESIDENT
- Total calculated
- $0
- Hours/week
- 1
-
Giovanni KotoriyGIOVANNI KOTORIY
SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
Kendra HarveyKENDRA HARVEY
TREASURER
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$100,000
TO SUPPORT THE DEVELOPMENT OF LIPID NANOPARTICLE TECHNOLOGY
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 24 June 2025
- IRS schema version
- 2024v5.2
- Source object
- 202501819349300220
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.